Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. A&Z Pharmaceutical, Inc.
WARNING LETTER
•A&Z Pharmaceutical, Inc.•June 13, 2023

A&Z Pharmaceutical, Inc. – FDA Warning Letter, Jun 13, 2023

Record Details

The FDA issued a Warning Letter to Ms. Li Xu, D-CAL USA, following a review of their websites (d-calusa.com, facebook.com/dcalusa/, facebook.com/mfitsupps/) in April 2023. The FDA determined that the product "Chewable Calcium 600MG with Vitamin D for Kids in Orange Flavor" is marketed with claims that establish it as a drug under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act), due to its intended use in the cure, mitigation, treatment, or prevention of disease.

Specific claims on the websites, such as those related to "VITAMIN D & IT’S BENEFITS," "CALCIUM DEFICIENCY|LOW CALCIUM SYMPTOMS," "WHAT IS CALCIUM? | CALCIUM BENEFITS," and "CONTROLLING BLOOD PRESSURE WITH THESE KEY MINERALS," indicate drug intent.

The product is deemed a "new drug" under section 201(p) of the Act because it is not generally recognized as safe and effective for its intended uses. Introducing or delivering a new drug into interstate commerce without prior FDA approval violates sections 301(d) and 505(a) of the Act.

Furthermore, the product is misbranded under section 502(f)(1) of the Act because it lacks adequate

Company
A&Z Pharmaceutical, Inc.
Inspection date
June 13, 2023
Product type
Food
Office
Division of Human and Animal Food Operations - East I
Person
  • Ronald M. Pace (Program Director)
View Company Profile

ID · 6ccdfac6-84d1-4d96-8ad5-6ea446796398

Violation Codes8
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 353(b)(1)(A)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore A&Z Pharmaceutical, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.